Synopsis

Source of validity: Scientific
Rating (out of 5): 5

Salicylates, most notably acetylsalicylic acid (aspirin), are scientifically validated agents for the treatment of fever. Their use dates back to the late 19th century, when aspirin was first synthesized and introduced as a therapeutic agent. The mechanism by which salicylates reduce fever involves the inhibition of cyclooxygenase (COX) enzymes, particularly COX-1 and COX-2. These enzymes are critical in the biosynthesis of prostaglandins, which are endogenous mediators responsible for elevating the hypothalamic set-point during fever. By reducing prostaglandin synthesis, salicylates lower the hypothalamic set-point, thereby reducing body temperature in febrile patients.

Numerous clinical trials and decades of clinical use have established the efficacy and safety of salicylates for fever reduction in adults. However, it is important to note that their use in children, especially those with viral infections, is contraindicated due to the risk of Reye's syndrome, a rare but serious condition. Non-specified "salicylate" could refer to a variety of compounds in this chemical class, but the antipyretic effect is well-characterized for aspirin and closely related agents.

Overall, the use of salicylates for fever is both historically rooted and scientifically validated, with a robust evidence base supporting their role as effective antipyretic medications in appropriate patient populations.

More about Salicylate (unspecified)
More about Fever

Other ingredients used for Fever

Other health conditions supported by Salicylate (unspecified)

Products containing Salicylate (unspecified)